Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina

Circulation

Volumn 103, Issue 25, 2001, Pages 3062-3068

  Bogaty, Peter ^a   Poirier, Paul ^a   Simard, Serge ^a   Boyer, Luce ^a   Solymoss, Susan ^b   Dagenais, Gilles R ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Angina; Coronary disease; Inflammation; Myocardial infarction; Risk factors

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR;

EID: 0035954249     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.25.3062     Document Type: Article

References (34)

1. Some lessons in cardiovascular epidemiology from Framingham
2. A comparison of coronary angiographic findings at acute and chronic first presentation of ischemic heart disease
3. Plaque fissuring: The cause of acute myocardial infarction, sudden ischaemic death and crescendo angina
4. The pathogenesis of coronary artery disease and the acute coronary syndromes
5. Association of recurrent myocardial infarction with hemostatic factors: A prospective study
6. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
7. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
8. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis
9. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
10. A prospective study of plasma homocyst (e)ine and risk of myocardial infarction in US physicians
11. The PLAT Study: Hemostatic function in relation to atherothrombotic events in cardiovascular patients: Principal results
12. Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin. C-peptide and plasminogen activator inhibitor-1
13. ECAT Angina Pectoris Study: Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography
14. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients: A case-control study
15. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
16. Lipoprotein (a) levels and risk of coronary heart disease in men: The lipid research clinics coronary primary prevention trial
17. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
18. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
19. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
20. Von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
21. C-reactive protein and its relation to cardiovascular risk factors: A population-based cross-sectional study
22. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
23. Production of C-reactive protein and risk of coronary events in stable and unstable angina
24. Atherogenic, hemostatic and other potential risk markers in subjects with previous isolated myocardial infarction compared to longstanding uncomplicated stable angina
25. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 Years of follow-up in the Framingham Study
26. Measurement of homocyst (e)ine in the prediction of arteriosclerosis
27. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women
28. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris
29. Intraindividual variability of fibrinogen levels and cardiovascular risk profile
30. The prognosis for patients with new-onset angina who have undergone cardiac catheterization
31. Inflammation in ischaemic heart disease
32. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
33. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
34. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction